Transfusion Diagnostics: Major Suppliers Strategic Assessments
This report presents extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. For each company the report provides: Sales Market shares Product portfolios Marketing tactics Technological know-how New products in R&D Collaborative arrangements Business strategies
Contains 50 pages
Contains 50 pages
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
BioRad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/GenProbe
Immucor
OrthoClinical Diagnostic
Proteome Sciences
Quest
Quidel
Roche
Siemens
Tecan
Thermo Fisher
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
BioRad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/GenProbe
Immucor
OrthoClinical Diagnostic
Proteome Sciences
Quest
Quidel
Roche
Siemens
Tecan
Thermo Fisher
More Publications
2015 CompetitiveWatch Transfusion Diagnostics: Major Suppliers Strategic Assessments
US$ 1,480.00
October 2015
50 pages
2016-2020 CompetitiveWatch Cancer Diagnostics: Major Suppliers Strategic Assessments
US$ 2,000.00
March 2016
80 pages
Cancer Diagnostics: Major Suppliers Strategic Assessments
US$ 2,000.00
June 2016
80 pages
2015 CompetitiveWatch Molecular Diagnostics: Major Suppliers Strategic Assessments
US$ 2,000.00
October 2015
120 pages
Molecular Diagnostics: Major Suppliers Strategic Assessments
US$ 2,000.00
June 2016
120 pages
